Wnt signaling in colorectal cancer: pathogenic role and therapeutic target

H Zhao, T Ming, S Tang, S Ren, H Yang, M Liu, Q Tao… - Molecular cancer, 2022 - Springer
Abstract Background The Wnt signaling pathway is a complex network of protein interactions
that functions most commonly in embryonic development and cancer, but is also involved in …

Genetic mechanisms of fertilization failure and early embryonic arrest: a comprehensive review

Y Wei, J Wang, R Qu, W Zhang, Y Tan… - Human …, 2024 - academic.oup.com
BACKGROUND Infertility and pregnancy loss are longstanding problems. Successful
fertilization and high-quality embryos are prerequisites for an ongoing pregnancy. Studies …

STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies

M Hashemi, S Abbaszadeh, M Rashidi, N Amini… - Environmental …, 2023 - Elsevier
Colorectal cancer (CRC) ranks as the third most aggressive tumor globally, and it can be
categorized into two forms: colitis-mediated CRC and sporadic CRC. The therapeutic …

BZW2 inhibition reduces colorectal cancer growth and metastasis

S Agarwal, F Afaq, P Bajpai, M Behring, HG Kim… - Molecular Cancer …, 2023 - AACR
Because survival of patients with metastatic colorectal cancer remain poor, there is an
urgent need to identify potential novel druggable targets that are associated with colorectal …

Targeting TRIP13 for overcoming anticancer drug resistance

L Zhao, S Ye, S Jing, YJ Gao, T He - Oncology Reports, 2023 - spandidos-publications.com
Cancer is one of the greatest dangers to human wellbeing and survival. A key barrier to
effective cancer therapy is development of resistance to anti‑cancer medications. In cancer …

MicroRNAs and colorectal cancer: clinical potential and regulatory networks

GY Osei, J Adu-Amankwaah, S Koomson… - Molecular Biology …, 2023 - Springer
Colorectal cancer (CRC) is a serious global health concern, with a high incidence and
mortality rate. Although there have been advancements in the early detection and treatment …

Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms

R Li, Y Wu, Y Li, W Shuai, A Wang, Y Zhu, X Hu… - European Journal of …, 2023 - Elsevier
Colorectal cancer (CRC), a tumor of the digestive system, is characterized by high
malignancy and poor prognosis. Currently, targeted therapy of CRC is far away from …

[HTML][HTML] Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma

F Afaq, S Agarwal, P Bajpai, S Al Diffalha, HG Kim… - Neoplasia, 2024 - Elsevier
Thyroid hormone receptor-interacting protein 13 (TRIP13) is involved in cancer progression,
but its role in pancreatic ductal adenocarcinoma (PDAC) is unknown. Thus, we assessed the …

TRIP13 Plays an Important Role in the Sensitivity of Leukemia Cell Response to Sulforaphane Therapy

L Liu, B Liao, R Fan, Y Liu, A Li, L Liu, Y Li, J Li - ACS Omega, 2024 - ACS Publications
Sulforaphane is one of the most characterized isothiocyanate compounds in cruciferous
vegetables and shows anticancer effects, especially antileukemia properties. However, the …

Onco-Pathogen mediated cancer progression and associated signaling pathways in cancer development

S Kannampuzha, AV Gopalakrishnan, H Padinharayil… - Pathogens, 2023 - mdpi.com
Infection with viruses, bacteria, and parasites are thought to be the underlying cause of
about 8–17% of the world's cancer burden, ie, approximately one in every five malignancies …